Is there a benefit for CYP2C19 genotype-guided antiplatelet treatment in elderly acute coronary syndrome patients?

Pharmacogenomics, Ahead of Print.

Source: Future Medicine: Pharmacogenomics - July 12, 2021 Category: Genetics & Stem Cells Authors: Wout WA van den Broek Jurri ën M ten Berg Source Type: research